Product Description
COVID-19 IgM/IgG rapid test is for identify past infections (immune response) for COVID-19 patient. It is suitable for define which stage are patient are and for follow-up recover status. Part of the immune response to infection is the production of antibodies including IgM and IgG.
According to the FDA, IgM antibodies to SARS-CoV-2 are generally detectable in blood several days after initial infection, although levels over the course of infection are not well characterized.
IgG antibodies to SARS-CoV-2 generally become detectable 10–14 days after infection although they may be detected earlier, and normally peak around 28 days after the onset of infection.
Features of Product
Less Sample To Get 2 Test Result in Sametime
Use 10ul serum/plasma through test card can get qualitative results of IgM and IgG antibodies of COVID-19.
Fast
Results available within 15 mins
Clear
Provide clear results that are easy to read
Easy & Reliable
Require minimal hands-on time
Provide accurate results and includes internal controls
Expected Usage
20 tests each. Suitable for the qualitative detection of Coronavirus (SARS-CoV-2 / COVID-19) S-Protein IgM/IgG antibodies in human serum, plasma.
This product is for in vitro diagnostic use, following guidance from the FDA for Emergency Use Authorizations of tests submitted for approval on March 16, 2020.
This test should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.